These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22988932)

  • 21. Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study.
    Franc S; Daoudi A; Pochat A; Petit MH; Randazzo C; Petit C; Duclos M; Penfornis A; Pussard E; Not D; Heyman E; Koukoui F; Simon C; Charpentier G
    Diabetes Obes Metab; 2015 Dec; 17(12):1150-7. PubMed ID: 26264812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extent and prevalence of post-exercise and nocturnal hypoglycemia following peri-exercise bolus insulin adjustments in individuals with type 1 diabetes.
    McCarthy O; Deere R; Churm R; Dunseath GJ; Jones C; Eckstein ML; Williams DM; Hayes J; Pitt J; Bain SC; Moser O; Bracken RM
    Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):227-236. PubMed ID: 33012641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing the replacement of basal insulin in type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era.
    Bolli GB; Andreoli AM; Lucidi P
    Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S43-52. PubMed ID: 21668336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin administered by needle-free jet injection corrects marked hyperglycaemia faster in overweight or obese patients with diabetes.
    de Wit HM; Engwerda EE; Tack CJ; de Galan BE
    Diabetes Obes Metab; 2015 Nov; 17(11):1093-9. PubMed ID: 26259978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycaemic control in type 2 diabetes mellitus patients undergoing major surgery: comparison of three subcutaneous insulin regimens.
    Mathur SK; Bansal A; Khan ZY
    J Indian Med Assoc; 2009 Nov; 107(11):759-61. PubMed ID: 20469779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes.
    Taplin CE; Cobry E; Messer L; McFann K; Chase HP; Fiallo-Scharer R
    J Pediatr; 2010 Nov; 157(5):784-8.e1. PubMed ID: 20650471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in insulin degludec dosing for multiple exercise sessions improves time spent in euglycaemia in people with type 1 diabetes: A randomized crossover trial.
    Moser O; Eckstein ML; Mueller A; Birnbaumer P; Aberer F; Koehler G; Sourij C; Kojzar H; Holler P; Simi H; Pferschy P; Dietz P; Bracken RM; Hofmann P; Sourij H
    Diabetes Obes Metab; 2019 Feb; 21(2):349-356. PubMed ID: 30221457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How much do I give? Dose estimation formulas for once-nightly insulin glargine and premeal insulin lispro in type 1 diabetes mellitus.
    King AB; Clark D; Wolfe GS
    Endocr Pract; 2012; 18(3):382-6. PubMed ID: 22440988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: A randomized controlled trial.
    Pettus J; Reeds D; Cavaiola TS; Boeder S; Levin M; Tobin G; Cava E; Thai D; Shi J; Yan H; Bautista E; McMillan J; Unger R; Henry RR; Klein S
    Diabetes Obes Metab; 2018 May; 20(5):1302-1305. PubMed ID: 29283470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of initial insulin dosage on blood glucose dynamics of children and adolescents with newly diagnosed type 1 diabetes mellitus.
    Wang Y; Gong C; Cao B; Meng X; Wei L; Wu D; Liang X; Li W; Liu M; Gu Y; Su C
    Pediatr Diabetes; 2017 May; 18(3):196-203. PubMed ID: 26947770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the counter-regulatory responses to hypoglycaemia in patients with type 1 diabetes during opiate receptor blockade with naltrexone.
    Naik S; Belfort-DeAguiar R; Sejling AS; Szepietowska B; Sherwin RS
    Diabetes Obes Metab; 2017 May; 19(5):615-621. PubMed ID: 27987236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Terbutaline and the prevention of nocturnal hypoglycemia in type 1 diabetes.
    Cooperberg BA; Breckenridge SM; Arbelaez AM; Cryer PE
    Diabetes Care; 2008 Dec; 31(12):2271-2. PubMed ID: 18782903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insulin glargine 300 Units · mL-1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 Units · mL-1.
    Becker RH; Dahmen R; Bergmann K; Lehmann A; Jax T; Heise T
    Diabetes Care; 2015 Apr; 38(4):637-43. PubMed ID: 25150159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of subcutaneous insulin management protocols and order sets in inpatient diabetes management.
    Houlden RL; Moore S; Cornish W; Tiwana K
    Can J Diabetes; 2014 Apr; 38(2):101-17. PubMed ID: 24690505
    [No Abstract]   [Full Text] [Related]  

  • 37. Pramlintide reduces the risks associated with glucose variability in type 1 diabetes.
    Kovatchev BP; Crean J; McCall A
    Diabetes Technol Ther; 2008 Oct; 10(5):391-6. PubMed ID: 18715216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined intake of caffeine and low-dose glucose to reduce exercise-related hypoglycaemia in individuals with type 1 diabetes on ultra-long-acting insulin degludec: A randomized, controlled, double-blind, cross-over trial.
    Kühne T; Wallace E; Herzig D; Helleputte S; Scott S; Pickles J; Melmer A; Stettler C
    Diabetes Obes Metab; 2024 Jul; 26(7):2645-2651. PubMed ID: 38558517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The GesTIO protocol experience: safety of a standardized order set for subcutaneous insulin regimen in elderly hospitalized patients.
    Franchin A; Maran A; Bruttomesso D; Corradin ML; Rossi F; Zanatta F; Barbato GM; Sicolo N; Manzato E
    Aging Clin Exp Res; 2017 Dec; 29(6):1087-1093. PubMed ID: 28238154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alanine and terbutaline in treatment of hypoglycemia in IDDM.
    Wiethop BV; Cryer PE
    Diabetes Care; 1993 Aug; 16(8):1131-6. PubMed ID: 8375243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.